Unichem Laboratories Quarterly Results for Trading Insights
UNICHEMLAB • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹-12 Cr
QSept 2025
Unichem Laboratories Quarterly Results Key Highlights
- Revenue of ₹600 Cr in Sept 2025 (+0.7% vs Mar 2025, +16.3% vs Sept 2024)
- Net Profit of ₹-12 Cr in Sept 2025 (-122.6% vs Mar 2025, -148.0% vs Sept 2024)
- EBITDA of ₹29 Cr in Sept 2025 (-68.8% vs Mar 2025)
- Operating Margin of 1.0% in Sept 2025 (-13.0pp vs Mar 2025)
- Earnings Per Share of ₹-1.69 in Sept 2025 (-122.5% vs Mar 2025)
Unichem Laboratories Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 600 | 596 | 533 | 516 | 438 | 0.7% | 16.3% |
| Net Profit (₹ Cr) | -12 | 53 | -11 | 25 | -129 | - | - |
| EBITDA (₹ Cr) | 29 | 93 | 29 | 64 | -94 | - | - |
| EPS (₹) | -1.69 | 7.52 | -1.49 | 3.50 | -18.37 | - | - |
| Operating Margin (%) | 1.0% | 14.0% | 4.0% | 11.0% | -23.0% | - | - |
Unichem Laboratories Share Price Trend Around Quarterly Results
Visualize Unichem Laboratories's 1-year price movement across quarterly results — ideal for logging trades in Unichem Laboratories share price
chart using Tickjournal. All values in ₹.
Related Pages for Unichem Laboratories
Additional stock information and data for UNICHEMLAB
Revenue Trend (₹ Cr)
Sept 2024
516
Jun 2025
533
Mar 2025
596
Sept 2025
600
Net Profit Trend (₹ Cr)
Sept 2024
25
Jun 2025
-11
Mar 2025
53
Sept 2025
-12
Operating Margin Trend (%)
Sept 2024
11.0%
Jun 2025
4.0%
Mar 2025
14.0%
Sept 2025
1.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Unichem Laboratories quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹422,330.94 Cr | 1760.2 | 14,875 | 3,125 | +10.8% | - | 21.0% | 135.4 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6642.5 | 2,860 | 689 | +7.1% | - | 24.1% | 255.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 3936.8 | 3,219 | 591 | +11.3% | - | 18.4% | 224.4 |
|
Cipla
Sept 2025 |
₹121,238.47 Cr | 1530.8 | 7,716 | 1,353 | +12.0% | - | 17.5% | 91.5 |
|
Dr Reddys Laborator…
Sept 2025 |
₹104,829.57 Cr | 1256.2 | 9,135 | 1,337 | +1.1% | - | 14.6% | 77.6 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores